are now
Press Release
Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts
March 4, 2020 | Press Release
Laval, Quebec, and Gosselies, Belgium, March 04, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners, and a leading […]
Announcing Nexelis, a new name with long experience in the world of immuno-science.
September 23, 2019 | Press Release
Laval, QC, and Seattle, WA, September 23, 2019 - Today, our merged affiliates, NEOMED-LABS, Pacific Biomarkers and PAIRimmune, are proud […]
NEOMED-LABS and Public Health England Announce a Strategic Agreement
June 27, 2019 | Press Release
Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are […]
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune
June 6, 2019 | Press Release
LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized […]
Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers
March 28, 2019 | Press Release
LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service […]